ArticleFrontiers in molecular biosciences2025
Blood metabolome shows signatures of metabolic dysregulation in obese and overweight subjects that can be predicted by machine learning applied to heart rate variability.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hypothalamic Control of Liver Health and Disease: From Circuits to Pathophysiology and Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Clinical Trials and Translational Advances in Metabolic Targeting.Cancer treatment and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Obesity and overweight are linked to metabolic disturbances, which contribute to the onset of diseases like type 2 diabetes (T2D) and cardiovascular disorders. Metabolic health is also closely linked to autonomic function, as measured by heart rate variability (HRV), making HRV a potential non-invasive indicator of metabolic status. While studies have examined metabolic changes with body mass index (BMI), the link between HRV and specific metabolic profiles in normal-weight (NW), overweight (OW), and obese (OB) individuals is less understood. Additionally, whether HRV can reliably predict key metabolites associated with metabolic dysregulation remains largely unexplored. Methods: This study uses targeted metabolomics to profile amino acids and acylcarnitines in a group of academic employees across BMI categories (NW, OW, and OB) and investigates correlations between HRV variables and these metabolites. Finally, a machine learning approach was employed to predict relevant metabolite levels based on HRV features, aiming to validate HRV as a non-invasive predictor of metabolic health. Results: NW, OW, and OB subjects showed different metabolic profiles, as demonstrated by sparse partial least square discriminant analysis (sPLS-DA). The main upregulated metabolites differentiating NW from OB were C6DC and C8:1, while C6DC and C10:2 were higher in OW than NW. Time- and frequency-domain HRV features show a good correlation with the regulated metabolites. Finally, our machine learning approach allowed us to predict the most regulated metabolites in OB and OW subjects using HRV metrics. Conclusion: Our study advances our understanding of the metabolic and autonomic changes associated with obesity and suggests that HRV could serve as a practical tool for non-invasively monitoring metabolic health, potentially facilitating early intervention in individuals with elevated BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.